BPC-157 is not approved by the FDA or EMA for medical use and is listed as a prohibited substance by the World Anti-Doping Agency (WADA)
The Bottom Line: Compelling Mechanisms Demand Rigorous Human Investigation BPC-157 presents a fascinating scientific paradox: extensive preclinical evidence spanning three decades demonstrates pleiotropic effects across multiple neurotransmitter systems, with antidepressant efficacy exceeding standard drugs in animal models, anxiolytic effects without dependence liability, neuroprotection in stroke and neurodegeneration models, and reversal of schizophrenia-like cognitive deficits
Refrigerate at 28C immediately
A slightly pricier vial that comes with a real, recent COA is usually the better buy than a cheaper one with no lab data at all
Life Sciences , 54 (5), PL63PL68
: 303760-60-3 Synonyms : 4-Hydroxy-N-(naphthalen-2-ylmethylene) benzohydrazide Source: PubChem In laboratory research, SLU-PP-332 is examined for its interaction with estrogen-related receptor systems and downstream pathway responses